Skip to content

Diuretic Resistance Measured by Sodium Excretion and Urine Output in Acute Heart Failure

Diuretic Resistance Measured by Sodium Excretion and Urine Output in Acute Heart Failure - DIURESIS-AHF

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000035526
Enrollment
800
Registered
2019-01-15
Start date
2019-01-15
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute Heart Failure

Interventions

None listed

Sponsors

Department of Cardiovascular Medicine, Juntendo University
Lead Sponsor
Kobe City Medical Center General Hospital, Kameda General Hospital, Tokai University, Toho University Omori Medical Center, Musashino Red Cross Hospital, Hamamatsu University School of Medicine, Yokohama Southern Kyosai Hospital, The University of Tokyo, Iwate Medical University, Tokyo Medical and Dental University (TMDU), Teikyo University
Collaborator

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1) Patients diagnosed as acute heart failure fulfilling all the below criteria - Dyspnea at rest or mild exertion - Age equal or above 20 - Show at least one sign of congestion inclusion peripheral edema, rale, JVD, congestion shown by chest Xp) - BNP >=100 pg/mL or NT-proBNP >=300 pg/mL 2) Prescribed at least 10mg oral furosemide at the time of admission 3) Needs treatment with iv furosemide 4) Expected to use urinary catheter at least 6 hours 5) Those who are not obviously inappropriate

Exclusion criteria

Exclusion criteria: 1) eGFR <15 mL/min/1.73m2 2) Cardiogenic shock 3) acute myocarditis, post heart transplantation, needs mechanical circulatory support 4) Already treated with iv furosemide before enrollment 5) Need emergent revascularization with 6) Need treatment with carperitide within 6 hours 7) No consent achieved

Design outcomes

Primary

MeasureTime frame
1. Urinary sodium excretion achieved within 6 hours 2. 180-day all-cause mortality

Countries

Japan

Contacts

Public ContactTakeshi Kitai

Kobe City Medical Center General Hospital Department of Cardiovascular Medicine

t-kitai@kcho.jp078-302-4321

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026